z-logo
open-access-imgOpen Access
Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance
Author(s) -
Jiwen Cheng,
Yanke Chen,
Pengwei Zhao,
Na Li,
Jianwen Lu,
Jianhui Li,
Zhengwen Liu,
Yi Lv,
Chen Huang
Publication year - 2017
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2017.5882
Subject(s) - hepatocellular carcinoma , oncogene , molecular medicine , clinical significance , microrna , biomarker , cell cycle , medicine , real time polymerase chain reaction , cancer , reverse transcription polymerase chain reaction , cancer research , gastroenterology , oncology , biology , messenger rna , gene , biochemistry
MicroRNAs (miRNAs/miRs) have been identified as important post-transcriptional regulators in healthy liver physiology and liver diseases. However, the clinical significance of miR-638 in hepatocellular carcinoma (HCC) remains unclear. The aim of the present study was to investigate the status of miR-638 expression in HCC and to determine its clinical significance. The expression of miR-638 was evaluated in 60 HCC tissues samples and HCC SMMC-7721, HepG2 and Hep3B cell lines using reverse transcription-quantitative polymerase chain reaction. The association between the expression of miR-638 and the clinicopathological characteristics of patients with HCC was analyzed. The proportion of HCC patients with low miR-638 expression was identified as 68.3% (41/60). Furthermore, significantly lower miR-638 expression was identified in HCC tissue samples compared with the healthy control group (P=0.031). miR-638 expression was significantly lower in SMMC-7721 (P=0.021), HepG2 (P=0.005) and Hep3B (P=0.003) cells compared with the healthy human hepatic HL-7702 cell line. In addition, miR-638 expression was correlated with α-fetoprotein levels (P=0.042) and portal vein invasion (P=0.025). The area under curve was identified as 0.71 (95% confidence interval=0.63-0.79; P=0.001). The cut-off value for miR-638 was the median 2 -Δ∆Cq =0.125. In conclusion, miR-638 may be involved in the progression of HCC and act as a potential biomarker for the prediction of HCC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here